comparemela.com

Page 4 - Between Oct News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Money laundering: Scammers set up companies and bank accounts in S pore remotely during Covid-19

Adjuvant nivolumab may be promising for treatment of completely resected Merkel cell carcinoma

1. Disease-free survival at 24 months was 84% in the nivolumab group compared to 73% in the observation group. 2. Grade 3-4 adverse events were more common in the nivolumab group, however, there were no reported deaths. Evidence Rating Level: 1 (Excellent) Study Rundown: Merkel cell carcinoma (MCC), an aggressive skin cancer, poses a clinical

Intranasal etripamil effective for conversion of paroxysmal supraventricular tachycardia

1. Median time to sinus conversion was 17.2 minutes in the etripamil group versus 53.5 minutes in the placebo group. 2. Twice as many patients in the etripamil group converted to sinus rhythm than placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: Symptomatic supraventricular tachycardia (SVT) can cause severe distress to patients. Current management includes

#VisualAbstract: Cognitive functional therapy, with or without movement sensor biofeedback, improves chronic low back pain

1. Patients assigned to cognitive functional therapy (CFT) reported improved quality-adjusted life-years versus usual care. 2. Both CFT groups were found to have significantly reduced societal costs compared to the usual care group. Evidence Rating Level: 1 (Excellent) Study Rundown: Chronic low back pain is the leading cause of disability worldwide. Cognitive functional therapy (CFT) is

Cognitive functional therapy, with or without movement sensor biofeedback, improves chronic low back pain

1. Patients assigned to cognitive functional therapy (CFT) reported improved quality-adjusted life-years versus usual care. 2. Both CFT groups were found to have significantly reduced societal costs compared to the usual care group. Evidence Rating Level: 1 (Excellent) Study Rundown: Chronic low back pain is the leading cause of disability worldwide. Cognitive functional therapy (CFT)

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.